Robert V. Emmons, M.D., FACP

Robert Emmons

Robert V. Emmons, M.D., FACP

  • Professor of Medicine

UofL Health - Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202
502-562-3367 - Academic Office
502-562-4543 - Patient Appointments

Clinical Expertise
Blood and Bone Marrow Transplantation; Hematology

Education and Training

  • Medical School: University of Cincinnati College of Medicine
  • Residency: University of Michigan Affiliated Hospitals
  • Fellowship: National Institutes of Health

Get To Know Dr. Emmons

Featured Publications

  • Hashmi H, Bhandari S, Kumar R, Tripathi P, Rhodes JB, Figg L, Baize T, Krem MM, Hegazi M, Emmons R. Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis. Hematol Oncol Stem Cell Ther. 2020 Dec;13(4):232-237. doi: 10.1016/j.hemonc.2020.03.002. Epub 2020 May 8. PMID: 32413417.
  • Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma. J Clin Oncol. 2020 Apr 10;38(11):1126-1137. doi: 10.1200/JCO.19.01740. Epub 2019 Oct 25. PMID: 31652094; PMCID: PMC7145586.
  • Hashmi H, Bhandari S, Dhanoa J, Wu X, Rai S, Figg L, Baize T, Krem M, Hegazi M, Emmons R. Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience. Cureus. 2020 Feb 5;12(2):e6893. doi: 10.7759/cureus.6893. PMID: 32190456; PMCID: PMC7058400.
  • Hashmi H, Dhanoa JS, Emmons R. Rare case of Bing-Neel syndrome treated successfully with ibrutinib. BMJ Case Rep. 2019 Jun 25;12(6):e230067. doi: 10.1136/bcr-2019-230067. PMID: 31243026; PMCID: PMC6605891.
  • Fidler C, Klumpp T, Mangan K, Martin M, Sharma M, Emmons R, Lu M, Kropf P. Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant. Am J Hematol. 2012 Feb;87(2):219-21. doi: 10.1002/ajh.22227. Epub 2011 Dec 21. PMID: 22189875.
  • Jordan WE 3rd, Emmons R, Vogl D, Morris GJ. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough? Semin Oncol. 2011 Jun;38(3):327-34. doi: 10.1053/j.seminoncol.2011.03.019. PMID: 21600358.
  • Emmons R, Morris GJ. Readers' responses to "Cancer of unknown primary site: advances in diagnostics". Semin Oncol. 2010 Dec;37(6):555. doi: 10.1053/j.seminoncol.2010.10.021. PMID: 21167373.
  • Shanbhag S, Smith MR, Emmons RV. Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation. Stem Cells Cloning. 2010 Jul 7;3:93-102. doi: 10.2147/sccaa.s7016. PMID: 24198514; PMCID: PMC3781733.
  • Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Hum Pathol. 2010 Jan;41(1):26-32. doi: 10.1016/j.humpath.2009.06.012. Epub 2009 Sep 4. PMID: 19733383.
  • Wu KN, Emmons RV, Lisanti MP, Farber JL, Witkiewicz AK. Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin. Cell Cycle. 2009 Nov 1;8(21):3601-5. doi: 10.4161/cc.8.21.9999. Epub 2009 Nov 4. PMID: 19838066.